Dec 11 (Reuters) - Phathom Pharmaceuticals PHAT.O:
PHATHOM PHARMACEUTICALS SUBMITS CITIZEN PETITION TO FDA SEEKING CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA® (VONOPRAZAN) TABLETS
PHATHOM: PETITION REQUESTS CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA 10 MG,20 MG TABLETS TO ACCURATELY REFLECT 10-YEAR NCE EXCLUSIVITY PERIOD
PHATHOM PHARMACEUTICALS INC: EXCLUSIVITY PERIOD IS UNTIL MAY 3, 2032
Source text: ID:nGNXMt0NF
Further company coverage: PHAT.O
((Reuters.Briefs@thomsonreuters.com;))